CN1043712A - The preparation method of quinoline carboxylic acid derivative - Google Patents

The preparation method of quinoline carboxylic acid derivative Download PDF

Info

Publication number
CN1043712A
CN1043712A CN89109448A CN89109448A CN1043712A CN 1043712 A CN1043712 A CN 1043712A CN 89109448 A CN89109448 A CN 89109448A CN 89109448 A CN89109448 A CN 89109448A CN 1043712 A CN1043712 A CN 1043712A
Authority
CN
China
Prior art keywords
logical formula
compound
described method
hydrolyzed
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN89109448A
Other languages
Chinese (zh)
Other versions
CN1031190C (en
Inventor
伊斯托万·赫米茨
盖扎·克里兹图里
莱里·瓦斯维利·尼·德布雷茨
阿格尼斯·霍瓦茨
玛丽亚·巴洛格
彼得·里特里
朱迪特·塞波斯
安妮科·帕杰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chinoin Private Co Ltd
Original Assignee
Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt filed Critical Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt
Publication of CN1043712A publication Critical patent/CN1043712A/en
Application granted granted Critical
Publication of CN1031190C publication Critical patent/CN1031190C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic System
    • C07F5/02—Boron compounds
    • C07F5/022—Boron compounds without C-boron linkages

Abstract

The present invention relates to a kind of new preparation general formula (I) compound (R 1And R 2Represent hydrogen or C 1-4Alkyl, R 2Represent C 1-4Alkyl, R 4, R 5And R 6Represent hydrogen or halogen) and the method for pharmaceutical salts.General formula (I) compound is known antiseptic-germicide.The advantage of this method is that preparation process is simple, the productive rate height, and the reaction times is short.

Description

The preparation method of quinoline carboxylic acid derivative
But the present invention relates to the 1-(halo that a kind of new preparation has logical formula I)-ethyl-7-(3,4, the piperazine that 5-replaces)-6,8-two fluoro-4-oxygen-1, the method for 4-dihydro-quinoline-3-carboxylic acid derivative and pharmaceutical salts thereof.
In logical formula I, R 1And R 3Represent hydrogen or C1-4 alkyl, R 2Represent the C1-4 alkyl, R 4, R 5And R 6Represent hydrogen or halogen.
A known class has the 7-(3 of logical formula I, 4, the piperazine that 5-replaces)-quinoline-3-carboxylic acid derivative has high anti-microbial activity and (sees Antimicrob.Agents Chemother 1987,31,854; Drugs of Fut.1986,11,578 26th Interscci.Conf.Antimicrob.Agents Chemother.1986, Abst.430-431; 25th Intersci.Conf.Antimicrob.Agents Chemother.1985,567).Can be by making 6,7,8-three fluoro-4-oxygen-1,4-dihydro-quinoline-3-carboxylic acid and cyclic amine reaction prepare these compounds (seeing German patent specification 3 433 924, Japanese patent specification 60 142 980,61 85 381 and 61 65 882).
The invention provides a kind of new preparation and have logical formula I (R wherein 1And R 3Represent hydrogen or C1-4 alkyl, R 2Represent the C1-4 alkyl, R 4, R 5And R 6Represent hydrogen or halogen) the quinoline-3-carboxylic acid derivative and the method for pharmaceutical salts, this method comprises makes the compound with logical formula II:
(wherein R represents halogen, contains the aliphatic acyloxy of 2-6 carbon atom or contains the aromatics acyloxy of 7-11 carbon atom, R 4, R 5And R 6Definition same as described above) with have the amine of logical formula III:
(R wherein 1, R 2And R 3Definition same as described above) or its reactant salt, and at after separating (or not separating), the logical formula IV compound that reaction is obtained:
(wherein R, R 1, R 2, R 3, R 4, R 5And R 6Definition same as described above) hydrolysis, if desired, the logical formula I compound that obtains thus is converted into its salt, perhaps be not converted into salt.
The advantage of the inventive method is to make the preparation of logical formula I compound to simplify, and productive rate height and reaction times are short.
Boron derivative with logical formula IV is new compound.
According to the embodiment of preferred the inventive method, directly will lead to the formula IV boron derivative and be converted into required logical formula I quinoline-3-carboxylic acid and need not separation.
If desired, can in the presence of inert organic solvents and acid binding agent, make the reaction of logical formula II boron derivative and logical formula III amine.
Inert organic solvents preferred amide (for example dimethyl formamide, N,N-DIMETHYLACETAMIDE), ketone (for example acetone, methylethylketone), ether (for example diox, tetrahydrofuran (THF), ether), ester (for example ethyl acetate, methyl acetate, ethyl propionate), sulfoxide (for example dimethyl sulfoxide (DMSO)), alcohol (for example methyl alcohol, ethanol, 1-decanol, butanols), nitrile (for example acetonitrile) and halogenated organic solvent (for example chloroform, ethylene dichloride).
Organic or inorganic alkali can be used as acid binding agent.In organic bases, can enumerate trialkylamine (for example triethylamine, Tributylamine), cyclammonium (pyridine, 1 for example, 5-diaza-bicyclo [5.4.0] 11 carbon-5-alkene, 1,5-diaza-bicyclo [4.3.0] ninth of the ten Heavenly Stems-5-alkene, 1,4-diaza-bicyclo [2.2.2] octane); The oxyhydroxide of mineral alkali preferred as alkali or alkaline-earth metal or carbonate.Therefore, can advantageously adopt salt of wormwood, saleratus, sodium hydroxide, calcium hydroxide etc. or excessive logical formula III amine as acid binding agent.
According to used solvent, the reaction of logical formula II boron derivative and logical formula III amine can be carried out under 10-200 ℃.Reaction times is in 0.1-10 hour scope.Reaction times is also depended on temperature of reaction.Carry out if be reflected under the higher temperature, can shorten the reaction times.Above-mentioned reaction conditions is preferred value, also can adopt other reaction conditions.
Can be after separating (also can without separate), will lead to the formula IV compound hydrolysis under acidity or alkaline condition is required logical formula I quinoline-3-carboxylic acid.If desired, can logical formula IV compound be precipitated out from reaction mixture by for example cooling, and can be by for example filtering or centrifugal it being separated.
Can be by carrying out alkaline hydrolysis in the heated in water solution of basic metal or alkaline earth metal hydroxides or carbonate.The preferred aqueous solution that uses sodium hydroxide, potassium hydroxide, yellow soda ash, salt of wormwood, calcium hydroxide.But, in hydrolysing step, also can use organic amine (for example diethylamine).
Can in inorganic acid aqueous solution, carry out acidic hydrolysis.A kind of preferable methods is to heat in hydrochloric acid, hydrogen bromide, sulfuric acid or phosphate aqueous solution, makes logical formula IV compound hydrolysis.Also can in organic acid (for example acetate, propionic acid etc.), be hydrolyzed.
The hydrolysis of logical formula IV compound also can with the miscible organic solvent of water in the presence of in aqueous medium, carry out.For example alcohol (for example methyl alcohol, ethanol), ketone (for example acetone), ether (for example diox), acid amides (for example dimethyl formamide), sulfoxide (for example dimethyl sulfoxide (DMSO)) or pyridine can be used for this purpose.
Can be by for example pH value of aqueous solution being adjusted to a suitable value and, perhaps, the logical formula I quinoline-3-carboxylic acid that obtains thus being separated by the lyophilize of aqueous reaction mixture by the crystallization of for example filtering or centrifugation is separated out.
Available known method will be led to the formula I compound and will be converted into its pharmaceutical salts.Be preferably formed acid salt, for example the salt that forms with halocarbon, sulfonic acid, sulfuric acid or organic acid.Can form muriate, bromide, arylsulphonate, metilsulfate, maleate, fumarate, benzoate etc.Logical formula I compound can form salt with basic metal or alkaline-earth metal or other metal ion etc.Therefore, can prepare sodium salt, sylvite, magnesium salts, silver salt and mantoquita etc.
Available currently known methods will lead to the formula I compound and pharmaceutical salts is converted into hydrate (for example semihydrate, trihydrate etc.).
The present invention further provides a kind of have logical formula IV (wherein R, R 1, R 2, R 3, R 4, R 5And R 6Definition same as described above) new compound.
Raw material with logical formula II can prepare according to following method: make 1-ethyl-6, and 7-8-three fluoro-4-oxygen-1,4-dihydro-quinoline-3-carboxylic acid (british patent specification 2,057,440) and a kind of boron derivative (compound that for example has general formula (V):
Figure 891094482_IMG11
(wherein R is halogen, contains the aliphatic acyloxy of 2-6 carbon atom or contain the aromatics acyloxy of 7-11 carbon atom)] or fluoroboric acid in water or organic medium, react.
Provided other details of the present invention in the following embodiments, but these embodiment can not limit protection scope of the present invention.
Embodiment 1
Make 31.9g(1-ethyl-6,7,8-three fluoro-1,4-dihydro-4-oxygen-quinoline-3-carboxylic ion-O 3, O 4)-two fluoro-boron and 57.1g2,6-dimethyl-piperazine reacted 3 hours down at 100 ℃ in the 150ml dimethyl sulfoxide (DMSO).Add 400ml 3%(w/v) aqueous sodium hydroxide solution, heat and be hydrolyzed in 2 hours.Filter reaction mixture is used 96%(w/v) acetate transfers to 7 with the pH value.With the logical clouds cooling of crystalline reaction mixture, leach the crystal of separating out, wash with water and drying.Obtain 29.9g 7-[3,5-dimethyl-Piperazino] 1-ethyl-6,8-two fluoro-1,4-dihydro-4-oxygen-quinoline-3-carboxylic acid.M.p.＝232-234℃。
Molecular formula C 17H 19F 2N 3O 3Ultimate analysis:
Calculated value: C=59.17% H=5.80% N=11.49%
Measured value: C=59.05% H=5.91% N=11.45%
Embodiment 2
According to embodiment 1 described method, make 31.9g(1-ethyl-6,7,8-three fluoro-1,4-dihydro-4-oxygen-quinoline-3-carboxylic ion-O 3, O 4)-two fluoro-boron and 50.1g 2-methyl-piperazine react in the 150ml dimethyl sulfoxide (DMSO).Obtain 30.6g 1-ethyl-6,8-two fluoro-1,4-dihydro-4-oxygen-7-(3-methyl-Piperazino)-quinoline-3-carboxylic acid.M.p.＝238-240℃。
Molecular formula C 17H 19F 2N 3O 3Ultimate analysis:
Calculated value: C=58.11% H=5.45% N=11.96%
Measured value: C=58.01% H=5.55% N=12.07%
Embodiment 3
According to embodiment 1 described method, make 39.9g(1-ethyl-6,7,8-three fluoro-1,4-dihydro-4-oxygen-quinoline-3-carboxylic ion-O 3, O 4)-two-(acetato--O)-boron and 50.1g 2-methyl-piperazine react in the 150ml dimethyl sulfoxide (DMSO).Obtain 30.2g 1-ethyl-6,8-two fluoro-1,4-dihydro-4-oxygen-7-(3-methyl-Piperazino)-quinoline-3-carboxylic acid.M.p.＝237-239℃。
Molecular formula C 17H 19F 2N 3O 3Ultimate analysis:
Calculated value: C=50.11% H=5.45% N=11.96%
Measured value: C=57.97% H=5.53% N=11.90%
Embodiment 4
According to embodiment 1 described method, make 42.7g(1-ethyl-6,7,8-three fluoro-1,4-dihydro-4-oxygen-quinoline-3-carboxylic ion-O 3, O 4)-two-(the propionic acid ion-O)-boron and 50.1g 2-methyl-piperazine reaction.Obtain 28.7g 1-ethyl-6,8-two fluoro-1,4-dihydro-4-oxygen-7-(3-methyl-Piperazino)-quinoline-3-carboxylic acid.M.p.＝237-239℃。
Molecular formula C 17H 19F 2N 3O 3Ultimate analysis:
Calculated value: C=58.11% H=5.45% N=11.96%
Measured value: C=57.99% H=5.52% N=12.10%

Claims (10)

1, the logical formula I compound of a kind of preparation
Figure 891094482_IMG2
(R wherein 1And R 3Represent hydrogen or C1-4 alkyl, R 2Represent the C1-4 alkyl, R 4, R 5And R 6Represent hydrogen or halogen) and the method for pharmaceutical salts, this method comprises makes logical formula II compound
(wherein R represents halogen, contains the aliphatic acyloxy of 2-6 carbon atom or contains the aromatics acyloxy of 7-11 carbon atom, R 4, R 5And R 6Definition same as described above) with logical formula III bridged piperazine derivatives
Figure 891094482_IMG4
(R wherein 1, R 2And R 3Definition same as described above) or its reactant salt, and in after separating (or without separating), the logical formula IV compound that reaction is obtained
(wherein R, R 1, R 2And R 3Definition same as described above) be hydrolyzed, if desired, the logical formula I compound that obtains thus is converted into its salt, perhaps be not translated into salt.
2, the described method of claim 1, this method is included under the existence of organic solvent (preferred amide, sulfoxide, ketone, alcohol, ether, ester or nitrile), makes the reaction of logical formula II compound and logical formula III amine.
3, the described method of claim 2, this method comprise with the dimethyl sulfoxide (DMSO) being organic solvent.
4, the described method of claim 1, this method are included in the reaction of leading to formula II compound and logical formula III compound under the existence of acid binding agent.
5, the described method of claim 4, this method comprise that with amine or excessive logical formula VI compound be acid binding agent.
6, the described method of claim 1, this method is included in the acidic medium and is hydrolyzed.
7, the described method of claim 6, this method are included under the existence of organic acid or mineral acid (preferred hydrochloric acid, sulfuric acid or acetate) and are hydrolyzed.
8, the described method of claim 1, this method is included in the alkaline medium and is hydrolyzed.
9, the described method of claim 8, this method are included under the existence of alkali metal hydroxide, alkaline earth metal hydroxides or organic bases (preferred triethylamine aqueous solution) and are hydrolyzed.
10, logical formula IV compound
(R wherein 1And R 3Represent hydrogen or C1-4 alkyl, R 2Represent the C1-4 alkyl, R 4, R 5And R 6Represent hydrogen or halogen).
CN89109448A 1988-12-22 1989-12-22 Process for preparation of quinoline carboxylic acid derivatives Expired - Fee Related CN1031190C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU6560/88 1988-12-22
HU886560A HU203746B (en) 1988-12-22 1988-12-22 Process for producing quinoline-carboxylic acid derivatives

Publications (2)

Publication Number Publication Date
CN1043712A true CN1043712A (en) 1990-07-11
CN1031190C CN1031190C (en) 1996-03-06

Family

ID=10971814

Family Applications (1)

Application Number Title Priority Date Filing Date
CN89109448A Expired - Fee Related CN1031190C (en) 1988-12-22 1989-12-22 Process for preparation of quinoline carboxylic acid derivatives

Country Status (11)

Country Link
JP (1) JP2825641B2 (en)
KR (1) KR0146335B1 (en)
CN (1) CN1031190C (en)
AT (1) AT397385B (en)
AU (1) AU622256B2 (en)
FR (1) FR2640974B1 (en)
GB (1) GB2245562B (en)
HU (1) HU203746B (en)
IL (1) IL92821A0 (en)
WO (1) WO1990006922A1 (en)
YU (1) YU47215B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2077490B1 (en) * 1992-11-18 1996-10-16 Marga Investigacion TRIMETILSILILIC ESTERS AND SOLVATES OF CHELATES OF QUINOLIN-3-CARBOXYL ACIDS. PREPARATION AND APPLICATION TO THE QUINOLON PROCESS.
NZ260530A (en) * 1994-05-16 1997-06-24 Nigel Paul Maynard Organoborate complexes of divalent metal; use as timber treament agents
ES2092963B1 (en) * 1995-04-12 1997-12-16 Sint Quimica Sa PROCEDURE FOR THE PREPARATION OF ACID 1-CICLOPROPIL-6-FLUORO-1, 4-DIHIDRO-7- (1S, 4S) -5-METHYL-2,5-DIAZABICICLO (2.2.1) HEPT-2-IL) -4 -OXO-3-QUINOLINCARBOXILICO AND ITS SALTS.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59122470A (en) * 1982-12-27 1984-07-14 Dai Ichi Seiyaku Co Ltd Preparation of quinoline-3-carboxylic acid derivative
US4550167A (en) * 1983-05-23 1985-10-29 Ethyl Corporation Preparation of 1-alkyl-1,4-dihydro-4-oxo-7-(4-pyridyl)-3-quinoline carboxylic acid
JPS6078986A (en) * 1983-10-07 1985-05-04 Dai Ichi Seiyaku Co Ltd Preparation of oxazine derivative
JPS6165882A (en) * 1984-09-06 1986-04-04 Hokuriku Seiyaku Co Ltd 1-ethyl-6,8-difluoro-1,4-dihydro-4-oxo-7-piperazinyquinoline-3-carboxylic ester derivative and its preparation
JPS6185381A (en) * 1984-10-04 1986-04-30 Hokuriku Seiyaku Co Ltd Preparation of 1-ethyl-6, 8-difluoro-1, 4-dihydro-4-oxo-7-piperazinylquinoline-3-carboxylic acid derivative
CA1306750C (en) * 1985-12-09 1992-08-25 Istvan Hermecz Process for the preparation of quinoline carboxylic acide
HU196782B (en) * 1985-12-09 1989-01-30 Chinoin Gyogyszer Es Vegyeszet Process for production of quinoline carbonic acid
US4738800A (en) * 1986-03-26 1988-04-19 Ciba-Geigy Corporation Process for the preparation of 1,4-diamino-2,3-dicyanoanthraquinones
HU198709B (en) * 1987-04-08 1989-11-28 Chinoin Gyogyszer Es Vegyeszet Process for producing quinoline-carboxylic acid derivatives
JPS6419069A (en) * 1987-07-14 1989-01-23 Dainippon Pharmaceutical Co Production of polyhalogenoquinoline derivative

Also Published As

Publication number Publication date
FR2640974B1 (en) 1994-02-18
YU243789A (en) 1991-02-28
ATA902489A (en) 1993-08-15
KR910700245A (en) 1991-03-14
GB2245562B (en) 1992-12-23
KR0146335B1 (en) 1998-08-17
HU203746B (en) 1991-09-30
JP2825641B2 (en) 1998-11-18
AU4748090A (en) 1990-07-10
AU622256B2 (en) 1992-04-02
AT397385B (en) 1994-03-25
CN1031190C (en) 1996-03-06
GB2245562A (en) 1992-01-08
YU47215B (en) 1995-01-31
WO1990006922A1 (en) 1990-06-28
IL92821A0 (en) 1990-09-17
HUT52086A (en) 1990-06-28
GB9018360D0 (en) 1990-10-24
FR2640974A1 (en) 1990-06-29
JPH03502803A (en) 1991-06-27

Similar Documents

Publication Publication Date Title
EP2342207B1 (en) Processes for the alkylation of norbuprenorphine with reduced impurity formation
CN1025028C (en) Process for preparing quinoline carboxylic acid derivatives
WO2004050663A2 (en) An improved process for the preparation of cefuroxime sodium
CN1025616C (en) Process for preparing quinoline carboxylic acid
CN1031190C (en) Process for preparation of quinoline carboxylic acid derivatives
CN102659817B (en) Preparation method of cefdinir
EP0351889B1 (en) Process for the preparation of a quinoline carboxylic acid
US20040092735A1 (en) Process for the preparation of cefuroxime sodium
WO2007013043A2 (en) Processes for the preparation of 7-amino-3-vinyl cephalosporanic acid
CN86102630A (en) The method for preparing 7-amino-3-propenylcephalosporanic acid and ester class thereof
CN107987074A (en) A kind of synthetic method of Pradofloxacin
US6555680B1 (en) Method for the preparation of ceftiofur sodium
CN1304373C (en) Method for preparing aripiprazole and its intermediate
KR102575537B1 (en) Pyrazolamine Reactive Crystallization
WO1987003586A1 (en) Process for the preparation of 1-methylamino-quinoline-carboxylic acid derivatives
JPS5934199B2 (en) Bis-trimethylsilylcefamandole and its manufacturing method
CA1072544A (en) Process for preparing penicillins
CN108570061B (en) Preparation method of zabbixing
RU2044734C1 (en) Method of synthesis of quinoline carboxylic acid or its pharmaceutically acceptable salts and compounds
KR0184037B1 (en) Method of preparing cephem derivatives
RU2641699C2 (en) METHOD OF PRODUCING (1-CYCLOPROPYL-6-FLUORO-1,4-DIHYDRO-8-METHOXY-7-[(4aS,7aS)-OCTAHYDRO-6H-PYRROLO[3,4-B]PYRIDIN-6-YL]-4-OXO-3-QUINOLINECARBOXYLIC ACID
KR830001970B1 (en) Method for preparing cephalosporin derivative
WO2003050125A1 (en) A new method for the preparation of ceftiofur sodium
HU195801B (en) Process for producing 1-ethyl-6-fluoro-7-piperazino-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid
JPH0649075A (en) Production of 3-hydroxymethylcephalosporanic acid derivative

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee